KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor

Autor: Bossini Castillo, L, Simeon, Cp, Beretta, L, Broen, J, Vonk, Mc, Callejas, Jl, Carreira, P, Rodriguez Rodriguez, L, Garcia Portales, R, Gonzalez Gay MA, Castellvi, I, Camps, Mt, Tolosa, C, Vicente Rabaneda, E, Egurbide, Mv, Ssg, Ss, Schuerwegh, Aj, Hesselstrand, R, Lunardi, Claudio, van Laar JM, Shiels, P, Herrick, A, Worthington, J, Denton, C, Radstake, Tr, Fonseca, C, Martin, J.

Publikováno v: Digital.CSIC. Repositorio Institucional del CSIC
instname
Arthritis Research and Therapy; 14(6), no R273 (2012)
Arthritis Research & Therapy
ARTHRITIS RESEARCH & THERAPY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

Introduction Potassium voltage-gated channel shaker-related subfamily member 5 (KCNA5) is implicated in vascular tone regulation, and its inhibition during hypoxia produces pulmonary vasoconstriction. Recently, a protective association of the KCNA5 l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764c27f875e985e6e6f8303c083b2cca
http://lup.lub.lu.se/record/3577366/file/3811111.pdf